You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial

Authors

  • Michelle V Dietz Department of Surgical oncology, Erasmus Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Katrien L A Quintelier Data Mining and Modeling for Biomedicine Group, VIB-UGent Center for Inflammation Research Elewaut Unit Molecular Immunology and Inflammatory Unit, Gent, Oost-Vlaanderen, BelgiumDepartment of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, Zuid-Holland, The NetherlandsDepartment of Applied Mathematics, Computer Science and Statistics, Ghent University, Gent, Belgium PubMed articlesGoogle scholar articles
  • Job P van Kooten Department of Surgical oncology, Erasmus Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Nadine L de Boer Department of Surgical oncology, Erasmus Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Madelief Vink Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Alexandra R M Brandt-Kerkhof Department of Surgical oncology, Erasmus Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Cornelis Verhoef Department of Surgical oncology, Erasmus Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Yvan Saeys Data Mining and Modeling for Biomedicine Group, VIB-UGent Center for Inflammation Research Elewaut Unit Molecular Immunology and Inflammatory Unit, Gent, Oost-Vlaanderen, BelgiumDepartment of Applied Mathematics, Computer Science and Statistics, Ghent University, Gent, Belgium PubMed articlesGoogle scholar articles
  • Joachim G J V Aerts Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Marcella Willemsen Department of Pulmonary Medicine, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Sofie Van Gassen Data Mining and Modeling for Biomedicine Group, VIB-UGent Center for Inflammation Research Elewaut Unit Molecular Immunology and Inflammatory Unit, Gent, Oost-Vlaanderen, BelgiumDepartment of Applied Mathematics, Computer Science and Statistics, Ghent University, Gent, Belgium PubMed articlesGoogle scholar articles
  • Eva V E Madsen Department of Surgical oncology, Erasmus Medical Center, Rotterdam, The Netherlands PubMed articlesGoogle scholar articles

Citation

Dietz MV, Quintelier KLA, van Kooten JP, et al
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial
Journal for ImmunoTherapy of Cancer 2023;11:e007070. doi: 10.1136/jitc-2023-007070
Online issue publication 
August 03, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.